Induced Pluripotent Stem Cells Market Share

Statistics for the 2023 & 2024 Induced Pluripotent Stem Cells market share, created by Mordor Intelligence™ Industry Reports. Induced Pluripotent Stem Cells share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Induced Pluripotent Stem Cells Industry

The induced pluripotent stem cells market is competitive and consists of several key players. The companies are focusing on adopting various key strategies such as mergers, collaborations, acquisitions, partnerships, and product launches to withhold their position in the market. Some of the companies in the market are Axol Bioscience Ltd., Cynata Therapeutics Limited, Evotec SE, FUJIFILM Cellular Dynamics, Inc., Ncardia, Pluricell Biotech, and REPROCELL USA, Inc. among others. 

Induced Pluripotent Stem Cells (iPSCs) Market Leaders

  1. Axol Bioscience Ltd.

  2. Cynata Therapeutics Limited

  3. Evotec SE

  4. FUJIFILM Cellular Dynamics, Inc.

  5. Ncardia

*Disclaimer: Major Players sorted in no particular order

Induced Pluripotent Stem Cells Market Concentration

Induced Pluripotent Stem Cells Production Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)